Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Pharma-Bio Serv (PBSV) over the last 11 years, with Q4 2025 value amounting to $579286.0.

  • Pharma-Bio Serv's Treasury Shares rose 573.94% to $579286.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $579286.0, marking a year-over-year increase of 573.94%. This contributed to the annual value of $579286.0 for FY2025, which is 573.94% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Treasury Shares is $613680.0, which was up 928.73% from $599230.0 recorded in Q3 2025.
  • Pharma-Bio Serv's Treasury Shares' 5-year high stood at $613680.0 during Q4 2025, with a 5-year trough of $404126.0 in Q1 2021.
  • Its 5-year average for Treasury Shares is $520591.0, with a median of $546079.0 in 2023.
  • As far as peak fluctuations go, Pharma-Bio Serv's Treasury Shares changed by 0.0% in 2021, and later skyrocketed by 2677.78% in 2022.
  • Quarter analysis of 5 years shows Pharma-Bio Serv's Treasury Shares stood at $420244.0 in 2021, then rose by 19.51% to $502236.0 in 2022, then grew by 6.84% to $536580.0 in 2023, then grew by 2.1% to $547843.0 in 2024, then increased by 5.74% to $579286.0 in 2025.
  • Its Treasury Shares was $579286.0 in Q4 2025, compared to $570084.0 in Q3 2025 and $565080.0 in Q2 2025.